The Valley Desk

ArticleNPJ precision oncologyPublished

Targeting CD47-SIRPa axis shows potent preclinical anti-tumor activity as monotherapy and synergizes with PARP inhibition

Read the publication ↗ Open access copy ↗

Regional connection

Listed An author affiliation on the Europe PMC record names Jefferson Einstein Montgomery Hospital, with Jefferson Health linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
NPJ precision oncology
Published
PubMed ID
37468567
PubMed Central ID
PMC10356752
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal